Researchers at the National Cancer Institute and Qiagen have used multiplexes of synthetic siRNAs corresponding to multiple gene targets to compress RNAi screen size in cell-based assays, according to a recent study.
They also demonstrated that multiplexed siRNAs could silence at least six genes to the same degree as if each of the genes was targeted individually.